Clinical Genomics

Biotechnology Research • Green Knoll, New Jersey, United States • 1-10 Employees

Company overview

Headquarters	1031 US Highway 202, Bridgewater, New Jersey 08807, US
Website	clinicalgenomicsinc.com
Employees	1-10
Socials

Key Contact at Clinical Genomics

Peter Jollie

Non Executive Director

About Clinical Genomics

At Clinical Genomics, we harness breakthrough science to create innovative and accessible ways to detect disease and enhance lives. Clinical Genomics is a privately held biotechnology company developing and marketing innovative products for colorectal cancer (CRC) diagnosis. With a broad intellectual property portfolio consisting of more than 95 patents, Clinical Genomics sells colorectal cancer screening and monitoring solutions. In 2016, Clinical Genomics launched Colvera™, a sensitive and specific blood-based circulating tumor DNA (ctDNA) test for colorectal cancer recurrence monitoring that detects methylated DNA from two genes, BCAT1 and IKZF1. Via its wholly-owned subsidiary Enterix Inc., the company offers the user-friendly, patient-preferred colorectal cancer screening InSure® FIT™ assay, an FDA-cleared fecal immunochemical test that detects blood in the stool. Clinical Genomics has offices and CLIA-registered laboratories in Bridgewater as well as FDA-registered and TGA-licensed IVD manufacturing in Edison, New Jersey and Sydney, Australia and a NATA-accredited laboratory in North Ryde, NSW Australia.

Clinical Genomics revenue & valuation

Annual revenue	$5,414,116
Revenue per employee	$1,805,000
Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues	$17,400,000
Total funding	No funding